This is the authors' abstract. We don't add key points for this paper.
A human plasma protein binds to cell-bound C3b, the major cleavage product of the third component of complement. Consequent upon this binding, C3b no longer functions in either the classical or alternative pathways. This C3b inhibitory activity is a property of a protein previously designated beta 1H on the basis of its electrophoretic mobility.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Whaley et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: